Keith Speights

Keith Speights

TMFFishBiz

Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles


The 10 Biggest Biotech Stocks

Here's how these biotech stocks became the biggest on the market -- and how their future prospects look.









Is Align Technology a Buy?

The maker of clear dental aligners faces big challenges, but it has big opportunities, too.